Publication | Closed Access

Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis

HepatologyBiliary TractMedicineLiver PhysiologyImmunologyProstaglandin E2 ProductionPathologyHepatotoxicityAcute Liver FailureMetabolismPrimary Biliary CirrhosisLiver DiseaseMetabolomicsLiverPharmacologyCholangiopathiesDrug-induced Liver InjuryOxidative Stress